OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of Immune-Related Prognostic mRNA and lncRNA in Patients with Hepatocellular Carcinoma
Dan Chen, Xiaoting Li, Hui Li, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 8
Dan Chen, Xiaoting Li, Hui Li, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 8
Showing 8 citing articles:
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 75
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 75
Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer
Yuchong Yu, Yao Liu, Yuhong Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Yuchong Yu, Yao Liu, Yuhong Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Transcriptomics analysis of LINC02202 /XBP1 axis in melanoma: Implications for drug targeting and PD ‐1 monoclonal antibody efficacy
Yuanyuan Shang, Haiqian Yang, Jian Cui, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 1
Yuanyuan Shang, Haiqian Yang, Jian Cui, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 1
The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma
Chenxi He, Xinying Zhu, Fanting Kong, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-26
Open Access | Times Cited: 8
Chenxi He, Xinying Zhu, Fanting Kong, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-26
Open Access | Times Cited: 8
Aggrephagy-related LncRNAs index: A predictor for HCC prognosis, immunotherapy efficacy, and chemosensitivity
Shengchun Feng, Chunyan Yang, Jun Wang, et al.
Technology and Health Care (2023) Vol. 31, Iss. 4, pp. 1429-1449
Closed Access | Times Cited: 3
Shengchun Feng, Chunyan Yang, Jun Wang, et al.
Technology and Health Care (2023) Vol. 31, Iss. 4, pp. 1429-1449
Closed Access | Times Cited: 3
Exploring the Regulatory Role of XIST-microRNAs/mRNA Network in Circulating CD4+ T Cells of Hepatocellular Carcinoma Patients
Lien‐Hung Huang, Cheng‐Shyuan Rau, Yueh‐Wei Liu, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1848-1848
Open Access | Times Cited: 3
Lien‐Hung Huang, Cheng‐Shyuan Rau, Yueh‐Wei Liu, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1848-1848
Open Access | Times Cited: 3
Construction and Validation of a Combined Anoikis and Autophagy Prognostic Signature for Hepatocellular Carcinoma
Zengjun Li, Hao Wang, Kai Cui, et al.
Research Square (Research Square) (2024)
Closed Access
Zengjun Li, Hao Wang, Kai Cui, et al.
Research Square (Research Square) (2024)
Closed Access
TMEM101 expression and its impact on immune cell infiltration and prognosis in hepatocellular carcinoma
Lu Kuang, Yilin Pang, Quangang Fang
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Lu Kuang, Yilin Pang, Quangang Fang
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
